Disc Medicine, Inc.
IRON
$59.14
-$0.85-1.41%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -94.03% | -75.02% | -59.76% | -44.54% | -43.08% |
| Total Depreciation and Amortization | 80.13% | 16.86% | -32.80% | 48.51% | 56.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 132.35% | 111.70% | 58.02% | 34.81% | 106.94% |
| Change in Net Operating Assets | 9.13% | -159.97% | -162.65% | 23,972.73% | 209.41% |
| Cash from Operations | -92.06% | -95.68% | -80.74% | -42.05% | -27.86% |
| Capital Expenditure | -84.75% | -2,208.47% | -1,085.71% | -914.96% | -467.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -34.79% | 41.05% | -32.94% | -- | -- |
| Cash from Investing | -34.88% | 40.59% | -33.47% | -444,701.57% | -328,362.92% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 140.84% | 25.99% | 20.28% | 142.91% | -5.49% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1,110.48% | -- | 13,881.03% | -14.21% | -103.71% |
| Cash from Financing | 116.85% | 44.74% | 39.05% | 150.97% | -8.80% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 39.69% | 70.77% | -58.36% | -307.00% | -201.28% |